First placebo-controlled trial of benznidazole evaluating safety and efficacy in Pediatric patients 6 to 12 years old with Chagas disease
Latest Information Update: 25 Jan 2018
At a glance
- Drugs Benznidazole (Primary)
- Indications Chagas disease
- Focus Therapeutic Use
- 07 Sep 2017 New trial record
- 29 Aug 2017 Results published in the FDA Media Release
- 29 Aug 2017 Based on the data from this and other trial (see profile 288394), the U.S. Food and Drug Administration has granted accelerated approval to benznidazole for use in children ages 2 to 12 years old with Chagas disease, as reported in a FDA media release.